Outlook Therapeutics, Inc. has announced a key development in the treatment of wet age-related macular degeneration (wet AMD) with the National Institute for Health and Care Excellence (NICE ...

Regenxbio's rolling BLA submission completion of RGX-121 for the treatment of patients with MPS II expected in Q1 of 2025.

Izervay (avacincaptad pegol) is a prescription injection used to treat severe age-related macular ... But wet AMD can cause faster and more severe vision loss than dry AMD. During Izervay ...

Mississauga, Ontario Tuesday, January 21, 2025, 14:00 Hrs [IST] ...

On completion of the scans and tests, he said: “You have early age-related macular degeneration.” When he saw my face fall, he added: “AMD – it’s very common.” My grandmother suffered.

The phase 1 clinical trial is a multicenter, open-label, dose-escalation study to assess drug safety via intravitreal ...

The Amsler grid is a simple and effective tool often used to detect early signs of macular degeneration. This is a grid of ...

including stem cells being used in the treatment of Parkinson’s disease, a heart valve capable of growing in vivo, and genetic therapies used in wet age-related macular degeneration (AMD).

EQS-News: Formycon AG / Key word (s): Regulatory Approval Formycon receives EU approval for FYB203 (aflibercept), a biosimilar to Eylea®, under the brand names AHZANTIVE® and Baiama® 20.01.2025 / ...

Jedd Comiskey, Senior Vice President, Head of Europe, highlights the recent NICE recommendation of LYTENAVA™ (bevacizumab gamma) for the ...

Age-related macular degeneration (AMD), which affects about 200 million people worldwide and can result in legal blindness, impairs an area of the eye (retina) used for reading, driving and many other ...